Clinical Trial Update: A Phase III Open-Label Extension Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures [Phase 3]

View source ↗

Summary

Phase III open-label extension study evaluating gabapentin as adjunctive therapy in Japanese pediatric patients with partial seizures completed; results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Epilepsy

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Epilepsies, Partial | Phase 3 | Status: COMPLETED | Results posted: 2011-12-20